Protofibril-Fibril Interactions Inhibit Amyloid Fibril Assembly by Obstructing Secondary Nucleation

Amyloid-beta peptides (A beta) assemble into both rigid amyloid fibrils and metastable oligomers termed A beta O or protofibrils. In Alzheimer's disease, A beta fibrils constitute the core of senile plaques, but A beta protofibrils may represent the main toxic species. A beta protofibrils accumulate at the exterior of senile plaques, yet the protofibril-fibril interplay is not well understood. Applying chemical kinetics and atomic force microscopy to the assembly of A beta and lysozyme, protofibrils are observed to bind to the lateral surfaces of amyloid fibrils. When utilizing A beta variants with different critical oligomer concentrations, the interaction inhibits the autocatalytic proliferation of amyloid fibrils by secondary nucleation on the fibril surface. Thus, metastable oligomers antagonize their replacement by amyloid fibrils both by competing for monomers and blocking secondary nucleation sites. The protofibril-fibril interaction governs their temporal evolution and potential to exert specific toxic activities.

Automated summary

The study found that in the assembly of A beta and lysozyme, protofibrils bind to the lateral surfaces of amyloid fibrils, inhibiting the self-proliferation of amyloid fibrils. This suggests that metastable oligomers counteract the replacement by amyloid fibrils through competing for monomers and blocking secondary nucleation sites.